Development of building projects
VERNIX PHARMA AS
Revenue 2025
NOK 0
Operating profit
NOK −30,000
Equity
NOK 154,000
Incorporated
1994
Share capital
NOK 243,000
Key figures · 2025
Current ratio
16.36
Equity ratio
97.8%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -19.4% | |
| Likviditet | ||
| Current ratio | 16.36 | |
| Working capital | 54k | |
| Soliditet | ||
| Equity ratio (%%) | 97.8% | |
| Debt-to-equity ratio | 0.02 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.